Assurant- 5.25% NT REDEEM 15/01/2061 USD 25 OverviewAssurant- 5.25% NT REDEEM 15/01/2061 USD 25's EBIT is $1.4B, below the Finance sector average of $330B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
As of the most recent data (June 2026), AIZN shows a EBIT of $1.4B. That compares with $950M in the prior-year period — up 47.9% year over year. That is below the Finance sector average of $330B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, AIZN's EBIT is now $1.4B (was $950M) — a 47.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Assurant- 5.25% NT REDEEM 15/01/2061 USD 25 is outperforming or lagging.
The Finance sector average EBIT is about $330B. Assurant- 5.25% NT REDEEM 15/01/2061 USD 25 is at $1.4B, which is lower that average. That is roughly 99.6% below the sector mean. Use the comparison chart on this page to see how AIZN stacks up against individual peers as well.
Tracking AIZN's ebit over time shows whether Assurant- 5.25% NT REDEEM 15/01/2061 USD 25 is scaling, shrinking, or reshaping that part of the business. The current reading is $1.4B That compares with $950M in the prior-year period — up 47.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has Assurant- 5.25% NT REDEEM 15/01/2061 USD 25's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $1.4B) with ownership activity and broader fundamentals.
